Holter, Event Monitor, or Implantable Loop Recorder: Which Rhythm Monitor Is Right for You
A 55-year-old woman comes to clinic because she's been having occasional palpitations for the last six months. They happen maybe once or twice a week, last anywhere from a few seconds to ten minutes, and resolve on their own. She's tried describing them to her doctor, but the descriptions all sound similar regardless of what's actually happening on the EKG. Her resting EKG in clinic is normal. The question is what kind of monitor will catch the rhythm during one of her episodes.
I'm Dr. Damian Rasch, a cardiologist in Encinitas. The decision between a Holter monitor, an event monitor, and an implantable loop recorder depends on how often your symptoms occur and how concerning the suspected rhythm is. Choosing the wrong monitor wastes time. A 24-hour Holter on a patient with monthly palpitations rarely catches anything. A 30-day event monitor on a patient with daily symptoms is overkill. An implantable loop recorder on a patient with frequent benign palpitations exposes them to a procedure they don't need. The right monitor matches the symptom frequency. This article walks through how the three monitors work, when each is right, and what the results mean.
How Each Monitor Works
Holter Monitor
A Holter monitor is a small device worn on a chest strap or attached with adhesive electrodes that records every heartbeat continuously for a fixed period, usually 24 to 48 hours, sometimes up to 14 days with newer patches. The patient wears the device, goes about their normal activities, and keeps a symptom diary. After the monitor period, the device is returned and the recording is analyzed by a cardiologist or specialized technician.
Modern Holter monitors are smaller and easier to wear than older systems. The Zio patch, for example, is a single adhesive patch worn for up to 14 days that records continuously and gets mailed back for analysis. These extended Holters bridge some of the gap between traditional 24-hour monitoring and longer-term monitoring approaches.
Event Monitor
An event monitor is worn for a longer period (typically 14 to 30 days) but doesn't record continuously. Instead, it records when the patient activates it (during a symptomatic episode) or when the monitor automatically detects an arrhythmia based on its programmed criteria. Some event monitors include cellular transmission, automatically uploading detected events to a monitoring center for review.
Event monitors come in several flavors. Loop recorders continuously buffer recent EKG data and save the buffer when activated, capturing the rhythm leading up to the symptom. Post-event recorders only save data after activation, missing the onset of the rhythm. Mobile cardiac telemetry (MCT) systems automatically detect and transmit arrhythmias without requiring patient activation, with most systems using cellular transmission for real-time review.
Implantable Loop Recorder (ILR)
An implantable loop recorder is a small device, about the size of a USB stick, implanted under the skin of the chest in a brief outpatient procedure. The device continuously monitors the heart's rhythm for up to three years, detecting arrhythmias automatically and transmitting them wirelessly to a monitoring service. The patient doesn't need to do anything once the device is implanted.
ILRs are the longest-duration option and are reserved for patients with infrequent but concerning symptoms. The implantation is minor (local anesthesia, small incision, takes about 15 minutes) but it is a procedure with all the usual procedural considerations.
Matching Monitor to Symptom Frequency
The single most important factor in choosing the right monitor is how often the patient is having symptoms.
Daily symptoms: a 24-hour or 48-hour Holter is usually sufficient to capture the rhythm during a symptomatic episode. The yield is high.
Symptoms several times per week: a 14-day patch monitor (extended Holter) is well-suited. The longer wear time increases the chance of capturing the rhythm during a symptomatic period.
Symptoms once a week or less: a 30-day event monitor or mobile cardiac telemetry is more likely to catch the rhythm. The patient activates the device when symptoms occur, and the recording is reviewed for what was happening at that moment.
Symptoms once a month or less: an implantable loop recorder is usually the right choice. The 30-day monitor isn't long enough; the patient might wear it and never have an episode. The ILR's 3-year monitoring window catches the rhythm even if episodes are months apart.
For patients with infrequent but very concerning symptoms (syncope, presyncope, palpitations associated with passing out), the ILR is often appropriate even when monthly Holter or event monitoring would have been a reasonable first try, because the consequences of missing the rhythm are severe.
Specific Indications
Palpitations Workup
Patients with palpitations and a normal resting EKG need ambulatory monitoring to capture the rhythm during a symptomatic episode. The choice of monitor follows the frequency rule above. Most patients with palpitations end up on a 14-day or 30-day monitor, which catches most clinically meaningful rhythms.
Syncope Evaluation
Patients with unexplained syncope and a non-diagnostic initial workup (including tilt table testing where appropriate) often need long-term monitoring to identify whether arrhythmia is the cause. The CRYSTAL-AF and ICTUS studies showed that ILRs identify causes of syncope that shorter-term monitoring misses. For patients with recurrent unexplained syncope, especially with concerning features (sudden onset, no warning, exertional, family history of sudden death), an ILR is often appropriate as the first-line monitoring strategy.
Cryptogenic Stroke
Patients who have had an ischemic stroke without an identifiable cause often have undiagnosed atrial fibrillation that's only intermittent. The CRYSTAL-AF trial showed that ILRs identify AFib in many of these patients, often months after the index stroke. Detection changes management to anticoagulation. ILRs are now standard of care for cryptogenic stroke evaluation.
Atrial Fibrillation Burden Quantification
Patients with known atrial fibrillation sometimes need quantification of how much AFib they're having (the AFib burden), especially after rhythm control interventions like ablation or antiarrhythmic medications. Continuous monitoring quantifies the burden more accurately than intermittent EKGs or symptom-based assessment. ILRs are useful for long-term burden quantification.
Suspected Bradyarrhythmia
Patients with intermittent presyncope, syncope, or symptoms suggestive of bradycardia who don't have a captured rhythm during their symptoms need monitoring. The choice between Holter, event monitor, and ILR follows the frequency rule. ILRs are often used when the symptom frequency is low but the consequences of missing significant bradycardia are high.
Following Catheter Ablation
After AFib ablation, monitoring assesses whether the rhythm has been successfully controlled. The intensity of monitoring depends on local protocol and patient preference, ranging from intermittent Holter at intervals to continuous ILR monitoring.
Channelopathy Surveillance
Patients with diagnosed long QT, Brugada, or CPVT who are being managed without an ICD sometimes have ILRs placed for arrhythmia surveillance. Detection of significant arrhythmic events can change risk stratification and management.
What the Reports Show
Holter Reports
Holter reports describe the basic rhythm (sinus rhythm, atrial fibrillation, etc.), heart rate range (minimum, maximum, average), pauses if any, ectopic beats (PACs and PVCs with frequency expressed as a percentage of total beats), and any documented arrhythmias. The report correlates the patient's symptom diary entries with the rhythm at those times. A symptom occurring with sinus rhythm is reassuring; a symptom occurring with a captured arrhythmia points to that arrhythmia as the cause.
Event Monitor Reports
Event monitor reports show the rhythm during patient-activated events and any auto-detected arrhythmias. Each captured event includes a brief EKG strip with rhythm interpretation. The clinical pattern emerges from looking at the captured events together with the patient's symptom log.
ILR Reports
ILR reports include automatic transmissions of detected arrhythmias, patient-activated events, and weekly or monthly summary transmissions. Significant findings (sustained AFib, prolonged pauses, ventricular tachycardia) trigger immediate notification of the monitoring physician. Most ILR systems include patient activator buttons for symptom-triggered recording.
Common Patient Questions
My Holter was normal but I still have palpitations. Now what?
A normal Holter doesn't rule out a rhythm issue if the symptoms didn't occur during the wear period. The next step is usually a longer-duration monitor, often a 14-day patch or a 30-day event monitor. If symptoms are very infrequent, an ILR may be appropriate as the next step. The Holter just sets a floor; persistent palpitations with no captured rhythm means we keep looking.
How is the patch different from a traditional Holter?
The Zio patch and similar adhesive patches are extended Holter monitors with longer wear times (up to 14 days vs. 24 to 48 hours). They're smaller and easier to wear (just an adhesive patch, no chest strap or wires). The trade-off is fewer EKG leads (typically a single lead vs. 2 or 3 leads on traditional Holters), which can occasionally limit rhythm interpretation. For most palpitation workups, the patch is excellent.
Can I still shower with these monitors?
It depends on the device. Many modern patch monitors are water-resistant and can be worn in the shower. Traditional Holter monitors and most chest-strap event monitors are not water-resistant, and you have to remove them for showering. The instructions vary by device, so check with your monitoring service.
How is the ILR procedure done?
The procedure is usually done in an outpatient setting under local anesthesia. The cardiologist makes a small incision on the chest, slides the device under the skin, and closes the incision with sutures or surgical glue. The procedure takes about 15 minutes. There's typically minimal discomfort afterward, and patients return to normal activities within a day or two.
Does the ILR transmit my information all the time?
The device records continuously but only transmits when triggered: by a detected significant arrhythmia, by patient activation, or during scheduled summary transmissions. The monitoring service reviews the data and notifies your cardiologist of significant findings. Routine transmissions and the volume of data are managed automatically.
How long does an ILR battery last?
Modern ILRs have batteries that last about 3 years. When the battery is near depletion, the device alerts the monitoring service and a decision is made about whether to remove the device (if monitoring is no longer needed) or replace it (if continued monitoring is appropriate).
Is the ILR removable?
Yes. ILRs are removed in a brief outpatient procedure similar to the implantation, sometimes when the battery is depleted or when monitoring is no longer needed. Some patients have the ILR removed once the diagnostic question has been answered; others leave it in for the full battery life for ongoing surveillance.
Why didn't my doctor go straight to the longest monitor?
Longer-duration monitoring isn't always better. A 24-hour Holter on a patient with daily symptoms gives the answer faster and at lower cost than a 30-day event monitor. Each step up in monitoring duration is appropriate when shorter monitoring hasn't given the answer or when the symptom frequency clearly requires longer monitoring. The ILR is reserved for situations where the symptom frequency is low enough that shorter monitoring isn't likely to capture the rhythm.
When to Escalate Care
Call 911 immediately for syncope, near-syncope with palpitations, sustained chest pain, or any sense of being unwell with rhythm-related symptoms. The monitor doesn't change emergency-level symptoms.
Contact your cardiologist or arrhythmia team the same day for new presyncope, palpitations associated with shortness of breath at rest, or any change in your symptom pattern. The monitor data is most useful when integrated with same-day clinical evaluation when symptoms are concerning.
Schedule a clinic visit within one to two weeks for stable, persistent palpitations that you've been managing on your own, especially if a monitor has been worn and reported negative results. Discussion of next-step monitoring strategy or alternative diagnoses is appropriate.
A Final Note From Me
The frustration patients describe most often with rhythm monitoring is wearing a monitor for the prescribed duration and never having a symptomatic episode during that window. The result is a normal monitor and ongoing symptoms with no answer. This isn't a failure of the test or the patient. It's a mismatch between symptom frequency and monitor duration. The right next step is a longer monitor, not abandoning the workup. Patients sometimes get told their negative monitor means there's nothing wrong, but that's only true if the monitor would have been likely to capture the rhythm if it were there. For infrequent symptoms, you need a longer monitor or eventually an ILR.
If you've had multiple monitors that all came back normal but you still have symptoms, ask your cardiologist about an ILR. The diagnostic yield over months to years is much higher than serial 30-day monitors, and the answer can change management substantially. The patients I worry about are the ones whose unexplained syncope or palpitations were dismissed after a normal short-term monitor without escalation. The patients I'm hopeful about are the ones who got a captured rhythm, a clear diagnosis, and a targeted treatment plan.
If you've had a captured rhythm on a monitor, the most important thing is to understand what it shows and what the management implications are. Atrial fibrillation changes the conversation to anticoagulation and rhythm management. Significant pauses or AV block changes the conversation to pacemaker. Ventricular tachycardia changes the conversation to ICD evaluation. Sinus tachycardia with normal EKG often points away from cardiac causes and toward evaluation for non-cardiac contributors. The captured rhythm is the start of the next conversation, not the end of the workup.
References
1. Sanna, Tommaso, Hans-Christoph Diener, Rod S. Passman, et al. "Cryptogenic Stroke and Underlying Atrial Fibrillation." New England Journal of Medicine 370, no. 26 (2014): 2478-2486.
2. Krahn, Andrew D., George J. Klein, Raymond Yee, Tony Hoch, and Allan C. Skanes. "The Role of an Implantable Loop Recorder in the Investigation of Unexplained Syncope." European Heart Journal 24, no. 13 (2003): 1257-1263.
3. Steinberg, Jonathan S., Niraj Varma, Iwona Cygankiewicz, et al. "2017 ISHNE-HRS Expert Consensus Statement on Ambulatory ECG and External Cardiac Monitoring/Telemetry." Heart Rhythm 14, no. 7 (2017): e55-e96.
4. Barrett, Paddy M., Ravi Komatireddy, Sharon Haaser, et al. "Comparison of 24-Hour Holter Monitoring with 14-Day Novel Adhesive Patch Electrocardiographic Monitoring." American Journal of Medicine 127, no. 1 (2014): 95.e11-95.e17.
5. Solbiati, Monica, Giorgio Costantino, Franca Dipaola, et al. "Syncope Recurrence and Mortality: A Systematic Review." Europace 17, no. 2 (2015): 300-308.
6. Brignole, Michele, Angel Moya, Frederik J. de Lange, et al. "2018 ESC Guidelines for the Diagnosis and Management of Syncope." European Heart Journal 39, no. 21 (2018): 1883-1948.
7. Kleindorfer, Dawn O., Amytis Towfighi, Seemant Chaturvedi, et al. "2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack." Stroke 52, no. 7 (2021): e364-e467.
8. Reiffel, James A., Alan H. Schwarzberg, Andrei D. Margulescu, et al. "Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population." JAMA Cardiology 2, no. 10 (2017): 1120-1127.
9. Edvardsson, Nils, Andrea Frykman, Robert van Mechelen, et al. "Use of an Implantable Loop Recorder to Increase the Diagnostic Yield in Unexplained Syncope." Europace 13, no. 2 (2011): 262-269.
10. Locati, Emanuela T., Susanna Moya, Maria Adelaide Branzi, et al. "External Prolonged Electrocardiogram Monitoring in Unexplained Syncope and Palpitations: Results of the SYNARR-Flash Study." Europace 18, no. 8 (2016): 1265-1272.
Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.